Fritextsökning
Innehållstyper
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Presenterar data från två kliniska studier
Sobi och partnern Biogen visar upp nya resultat på kongress i Kanada.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Lovande behandling mot fentanylmissbruk
Camurus redovisar fas 3-data för Buvidal.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Dubbdäck tar fler liv än de räddar
Dubbarna river upp asfalt, vilket skördar fler liv än dubbarna räddar, enligt en ny studie inom ramen för programmet Mistra Environmental Nanosafety.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Får fängelsestraff för Crispr-bebisar
Tre års fängelse och böter blir forskaren He Jiankuis straff för sitt arbete med att ta fram världens första genmodifierade bebisar.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Så får branschen umgås med vården
Nytt samverkansavtal reder ut spelreglerna när life science-industrin ska interagera med anställda inom vård och omsorg.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Specialisering ska lösa BMA-brist
Allt fler utbildar sig till biomedicinska analytiker. Ändå förutspås en framtida brist på yrkesgruppen samtidigt som specialiserade utbildningar efterfrågas.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Pengar till smarta minifabriker
För att främja digitaliserad svensk industri finansierar Vinnova åtta projekt som ska bana väg för framtida digital industri. Smarta minifabriker för läkemedels...
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
BREAKING